Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Lee Jackson | Nov 11, 2014 at 9:10 AM EST

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation…

Jon C. Ogg | Nov 10, 2014 at 8:15 AM EST

The Shame and Lessons of a Dendreon Bankruptcy

Dendreon has committed the ultimate sin by filing for bankruptcy protection.

Paul Ausick | Nov 7, 2014 at 7:45 AM EST

Humana Earnings Hit by High Drug Costs; Guidance Won’t Cheer Investors Either

Humana reported disappointing third-quarter 2014 results before markets opened Friday morning.

Chris Lange | Nov 5, 2014 at 2:00 PM EST

Inotek Pharma Files for IPO

Inotek Pharmaceuticals Corp. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Chris Lange | Nov 5, 2014 at 12:00 PM EST

Key Analyst Sees Upside in Medical Devices After Midterm Elections

Oppenheimer has released its list of potential post-election winners in the medical device industry.

Chris Lange | Nov 4, 2014 at 10:10 AM EST

Credit Suisse Sees $70 Billion Biosimilars Land Grab

Credit Suisse released its first edition of the "Credit Suisse Biosimilars 101" series of notes, offering analysis and impact of…

Jon C. Ogg | Nov 3, 2014 at 2:00 PM EST

MannKind Spending Trends See Improvements

MannKind reported its third-quarter financial results on Monday morning.

Chris Lange | Nov 3, 2014 at 12:25 PM EST

Is Geron Back From the Dead?

The FDA gave Geron some good news Monday morning when it removed the clinical hold on the its investigational new…

Chris Lange | Oct 31, 2014 at 11:30 AM EDT

Aegerion Pharmaceuticals Plunges to New 52-Week Low

In the wake of a reported net loss on disappointing sales of its lead product, Aegerion Pharmaceuticals shares lost a…

Chris Lange | Oct 30, 2014 at 2:23 PM EDT

Lakeland Living Up to Production Promises

Lakeland.comLakeland Industries Inc. (NASDAQ: LAKE) gave an update Thursday on its business activity in the wake of the Ebola crisis.…

Lee Jackson | Oct 30, 2014 at 8:55 AM EDT

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

A new research note from Cowen focuses on health care companies that have released earnings and offer investors reasons to…

Lee Jackson | Oct 29, 2014 at 8:15 AM EDT

Analyst’s Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings

The analysts at Piper Jaffray are very positive on four top specialty pharmaceutical stocks with potential for a strong fourth-quarter…

Chris Lange | Oct 29, 2014 at 7:55 AM EDT

Gilead Sciences Earnings Miss on Dwindling Sovaldi Sales

Gilead Sciences reported disappointing third-quarter results after the market close on Monday.

Chris Lange | Oct 28, 2014 at 11:55 AM EDT

What to Look For in Gilead Sciences Earnings Report

Gilead Sciences is set to report its third-quarter earnings after the U.S. markets close on Tuesday.

Paul Ausick | Oct 27, 2014 at 4:33 PM EDT

Amgen Posts 52-Week High, Beats It Again After Earnings

Amgen reported better-than-expected third-quarter 2014 results after markets closed Monday afternoon.

1 … 276 277 278 279 280 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

The Shame and Lessons of a Dendreon Bankruptcy

Humana Earnings Hit by High Drug Costs; Guidance Won’t Cheer Investors Either

Inotek Pharma Files for IPO

Key Analyst Sees Upside in Medical Devices After Midterm Elections

Credit Suisse Sees $70 Billion Biosimilars Land Grab

MannKind Spending Trends See Improvements

Is Geron Back From the Dead?

Aegerion Pharmaceuticals Plunges to New 52-Week Low

Lakeland Living Up to Production Promises

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

Analyst’s Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings

Gilead Sciences Earnings Miss on Dwindling Sovaldi Sales

What to Look For in Gilead Sciences Earnings Report

Amgen Posts 52-Week High, Beats It Again After Earnings

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

‘Your Knowledge of Money and How It Works Is Nil’: Suze Orman to 62-Year-Old Who Nearly Locked His Wife Into $605 a Month

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

Health and Healthcare Articles

All Health and Healthcare Articles

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

The Shame and Lessons of a Dendreon Bankruptcy

Humana Earnings Hit by High Drug Costs; Guidance Won’t Cheer Investors Either

Inotek Pharma Files for IPO

Key Analyst Sees Upside in Medical Devices After Midterm Elections

Credit Suisse Sees $70 Billion Biosimilars Land Grab

MannKind Spending Trends See Improvements

Is Geron Back From the Dead?

Aegerion Pharmaceuticals Plunges to New 52-Week Low

Lakeland Living Up to Production Promises

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

Analyst’s Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings

Gilead Sciences Earnings Miss on Dwindling Sovaldi Sales

What to Look For in Gilead Sciences Earnings Report

Amgen Posts 52-Week High, Beats It Again After Earnings

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

‘Your Knowledge of Money and How It Works Is Nil’: Suze Orman to 62-Year-Old Who Nearly Locked His Wife Into $605 a Month

Featured Reads

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.